Sonacare Medical raises $200M to expand AI ultrasound therapy

What's the deal? Sonacare Medical, known commercially as Sonablate, has raised $200M in funding. Eleven VenturesDealroom has a profile for this one. Try Dealroom → backed the round.

What's the endgame? Led by CEO Richard YangDealroom has a profile for this one. Try Dealroom →, the Charlotte-based company develops AI-powered, image-guided therapeutic ultrasound technologies for non-invasive treatment across prostate tissue ablation, oncology, neuromodulation, cardiovascular disease, and women's health.

Where's it expanding? Sonacare plans to support commercialisation across the Middle East and North Africa, evaluate regional assembly and manufacturing in Saudi Arabia, and establish a Gulf Cooperation Council headquarters.

What's the money for? The funds will accelerate global development, commercialisation, and adoption of the company's precision medicine technologies.

Read more: FinSMEs

Image credit: Generated with Gemini